Farmacia
Facultad
Hospital Universitario Son Espases
Palma, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Son Espases (89)
2024
-
BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury
Biomedicine and Pharmacotherapy, Vol. 174
2023
-
Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing
Enfermedades Infecciosas y Microbiologia Clinica
-
An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)
Frontiers in Microbiology, Vol. 14
-
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923
-
Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients
Clinical Microbiology and Infection, Vol. 29, Núm. 4, pp. 538.e7-538.e13
-
Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)
Frontiers in Microbiology
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
-
Patient-reported outcome measures in severe asthma: an expert consensus
Journal of Asthma
-
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
The Lancet Regional Health - Europe, Vol. 34
-
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2022
-
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Frontiers in Microbiology, Vol. 13
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172
-
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software
Frontiers in Microbiology, Vol. 12
-
Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain
AIDS Research and Human Retroviruses, Vol. 38, Núm. 6, pp. 433-440
2021
-
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699
-
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379
-
Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance
JAC-Antimicrobial Resistance, Vol. 3, Núm. 3
-
Gestión del proceso posanalítico en los laboratorios clínicos según los requisitos de la norma ISO 15189:2012. Consideraciones sobre la revisión, notificación y comunicación de los resultados
Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 61-70